Please login to the form below

Not currently logged in
Email:
Password:

Drugs to carry barcodes and more secure packaging

The European Commission has announced proposals to improve the European pharmaceutical market, providing more information to patients and protecting them from counterfeit medicines

The European Commission has announced proposals to improve the European pharmaceutical market, providing more information to patients and protecting them from counterfeit medicines.

The Commission is proposing the introduction of mandatory safety features such as seals on packages and serial codes, in a bid to protect consumers from counterfeit medicines.

A further measure would require drug manufacturers to audit the companies that manufacture the active ingredients in their products. Counterfeit drugs are a growing problem and global sales are expected to reach €58bn by 2010.

Presently, access to information about products differs across different countries in Europe. It is proposed that the industry should be permitted to publish non-promotional product information in health-related publications or on the internet.

Authorities in each country would be responsible for monitoring this information to ensure it does not lead to direct-to-consumer advertising of prescription medicine.

Commission vice president and commissioner for enterprise and industry, Günter Verheugen, said that Europeans should be informed about available medicines and treatments "since their health is at stake."

11th December 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics